Reviewing the role and contributions of the Wellcome Sanger Institute and Genome Campus
Jan 20, 2021
RAND Europe was commissioned by Wellcome to analyse the role and contribution of the Sanger Institute and the Wellcome Genome Campus within the field of genetics and genomics, set within the context of four comparator organisations.
|PDF file||2.8 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
RAND Europe was commissioned by Wellcome to analyse the role and contribution of the Wellcome Sanger Institute and the Wellcome Genome Campus within the field of genetics and genomics. The study also looked at four comparator organisations—the Broad Institute, Wellcome Centre for Human Genetics, Janelia Research Campus and the National Human Genome Research Institute. The methods for this study consisted of desk research, case studies, interviews and bibliometric analysis.
Our review found that the main strengths of the Sanger Institute and Genome Campus centre around their leadership and convening role in many international research collaborations, which is also a strength for other large research institutes such as the Broad Institute. The Sanger Institute prioritises openness in sharing data and tools and publishing research, which helps them achieve impact from their work. However, this approach has meant that commercialisation of research has not been as strong as compared to other organisations. The field of genetics and genomics is advancing rapidly, particularly due to availability and affordability of high throughput sequencing technologies, which has changed the competitive advantage that such technologies offer to organisations. The next challenge will be to find a direction for these organisations to explore that fits with their scale, operating environments, unique strengths and values. In the case of Sanger, this means finding an approach that capitalises on their ethos of openness, data sharing and collaboration to shape the development of the field over the coming years.
Review of Wellcome Sanger Institute and Wellcome Genome Campus
Case study structure
This research was commissioned by Wellcome and conducted by RAND Europe.
This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.